Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of Novel CTP/BNZ Mouthwash vs Tantum Verde in Healthy Subjects
NCT03706781Phase 1Completed
- Sponsor
- Angelini Pharma
- Start
- Nov 2017
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 1, randomised trial of cetylpyridinium chloride and benzydamine in Oral inflammation (2 arms), sponsored by Angelini Pharma. Primary endpoint: Change in Local Adverse Reactions at Day 8. Started Nov 2017; status: completed.
02
Drugs
cetylpyridinium chloridebenzydamine
03
Conditions
Oral inflammation
Beyond the preview
Go deeper on NCT03706781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03706781.